InvestorsHub Logo
Followers 44
Posts 750
Boards Moderated 0
Alias Born 08/25/2020

Re: None

Tuesday, 04/23/2024 11:57:26 AM

Tuesday, April 23, 2024 11:57:26 AM

Post# of 45303
If they continue to get good results for the other potential drugs. Then I would lean towards a buyout. If it remains just one drug. Then a partnership is more likely. Either way. the share price jumps and we benefit as well as the rest of the world. Just the pain med alone would be a enormous to say the least. No guess but $5 a share is not unrealistic. The share structure of the company is pretty good without billions upon billions of outstanding shares.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News